Medartis Holding AG 2024 AR2
The report highlights Medartis' strategic and financial achievements in 2024, including a 12% core sales growth at constant exchange rates and an improved core EBITDA margin of 19.0%. Key milestones include the acquisition of a 51% stake in NeoOrtho to enter the Latin American value segment and the submission of near-term emission reduction targets to the Science-Based Targets initiative (SBTi) for validation. On the environmental front, the company completed its transition to 100% LED lighting at its Basel headquarters, reducing lighting energy consumption by 60%. Additionally, Medartis implemented the Task Force on Climate-related Financial Disclosures (TCFD) recommendations and launched a medical plastic recycling pilot project.
Company: Medartis Holding AG
Sector: Health Care
Country: Switzerland
Year: 2024
Type: AR2
Pages: 192
Medartis Holding AG
Annual Report
The report highlights Medartis' strategic and financial achievements in 2024, including a 12% core sales growth at constant exchange rates and an improved core EBITDA margin of 19.0%. Key milestones include the acquisition of a 51% stake in NeoOrtho to enter the Latin American value segment and the submission of near-term emission reduction targets to the Science-Based Targets initiative (SBTi) for validation. On the environmental front, the company completed its transition to 100% LED lighting at its Basel headquarters, reducing lighting energy consumption by 60%. Additionally, Medartis implemented the Task Force on Climate-related Financial Disclosures (TCFD) recommendations and launched a medical plastic recycling pilot project.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Water Consumption
Women on Board
Workplace Fatalities
Employees